NEW YORK, Aug. 9, 2017 /PRNewswire/ -- About Pediatric Medicines
The pediatric drug market plays a pivotal role in the pharmaceutical industry. There are several vendors, who provide healthcare services and products for pediatric population. The pediatric medicines market is one of the important segments in the pharmaceutical industry. Infants are prone to infections owing to their under-developed immune system. The presence of a large pediatric population, especially in APAC combined with the population being more prone to infections and illness will increase the demand for pediatric medicines.
Read the full report: http://www.reportlinker.com/p05048548/Global-Pediatric-Medicines-Market.html
The pediatric medicines market is one of the emerging markets in the pharmaceutical sphere with huge unmet needs and requires support for better innovation and higher R&D investments.
Technavio's analysts forecast the global pediatric medicines market to grow at a CAGR of 4.97% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global pediatric medicines market for 2017-2021. To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Pediatric Medicines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GSK
• Novartis
• Pfizer
• Sanofi
Other prominent vendors
• Abbott
• Bristol-Myers Squibb
• Cipla
• Eisai Pharmaceuticals
• Eli Lilly
• F. Hoffman-La Roche
• Glenmark
• Helsinn Healthcare
• Heron Therapeutics
• Ipca Laboratories
• Lupin Pharmaceuticals
• Merck Sharp & Dohme
• RedHill
• Sun Pharmaceutical Industries
• Takeda Pharmaceutical
Market driver
• High pediatric population
• For a full, detailed list, view our report
Market challenge
• Usage of off-label drugs
• For a full, detailed list, view our report
Market trend
• Inorganic growth strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
Read the full report: http://www.reportlinker.com/p05048548/Global-Pediatric-Medicines-Market.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article